Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
- PMID: 32409590
- DOI: 10.1136/gutjnl-2019-319990
Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
Abstract
Objectives: To characterise the association between type 2 diabetes mellitus (T2DM) subtypes (new-onset T2DM (NODM) or long-standing T2DM (LSDM)) and pancreatic cancer (PC) risk, to explore the direction of causation through Mendelian randomisation (MR) analysis and to assess the mediation role of body mass index (BMI).
Design: Information about T2DM and related factors was collected from 2018 PC cases and 1540 controls from the PanGenEU (European Study into Digestive Illnesses and Genetics) study. A subset of PC cases and controls had glycated haemoglobin, C-peptide and genotype data. Multivariate logistic regression models were applied to derive ORs and 95% CIs. T2DM and PC-related single nucleotide polymorphism (SNP) were used as instrumental variables (IVs) in bidirectional MR analysis to test for two-way causal associations between PC, NODM and LSDM. Indirect and direct effects of the BMI-T2DM-PC association were further explored using mediation analysis.
Results: T2DM was associated with an increased PC risk when compared with non-T2DM (OR=2.50; 95% CI: 2.05 to 3.05), the risk being greater for NODM (OR=6.39; 95% CI: 4.18 to 9.78) and insulin users (OR=3.69; 95% CI: 2.80 to 4.86). The causal association between T2DM (57-SNP IV) and PC was not statistically significant (ORLSDM=1.08, 95% CI: 0.86 to 1.29, ORNODM=1.06, 95% CI: 0.95 to 1.17). In contrast, there was a causal association between PC (40-SNP IV) and NODM (OR=2.85; 95% CI: 2.04 to 3.98), although genetic pleiotropy was present (MR-Egger: p value=0.03). Potential mediating effects of BMI (125-SNPs as IV), particularly in terms of weight loss, were evidenced on the NODM-PC association (indirect effect for BMI in previous years=0.55).
Conclusion: Findings of this study do not support a causal effect of LSDM on PC, but suggest that PC causes NODM. The interplay between obesity, PC and T2DM is complex.
Keywords: cancer epidemiology; diabetes mellitus; obesity; pancreatic cancer.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Causal effect of obesity and adiposity distribution on the risk of pressure ulcers and potential mediation by type 2 diabetes mellitus: insights from multivariable mendelian randomization and mediation analysis.Arch Dermatol Res. 2024 Aug 20;316(8):550. doi: 10.1007/s00403-024-03299-0. Arch Dermatol Res. 2024. PMID: 39162722
-
The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study.J Natl Cancer Inst. 2017 Sep 1;109(9):djx012. doi: 10.1093/jnci/djx012. J Natl Cancer Inst. 2017. PMID: 28954281 Free PMC article.
-
Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer.J Med Genet. 2020 Dec;57(12):820-828. doi: 10.1136/jmedgenet-2019-106200. Epub 2020 Feb 17. J Med Genet. 2020. PMID: 32066631
-
Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.J Exp Clin Cancer Res. 2018 Dec 19;37(1):319. doi: 10.1186/s13046-018-0963-4. J Exp Clin Cancer Res. 2018. PMID: 30567565 Free PMC article. Review.
-
The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.J Cell Mol Med. 2020 Jul;24(14):7706-7716. doi: 10.1111/jcmm.15413. Epub 2020 May 26. J Cell Mol Med. 2020. PMID: 32458441 Free PMC article. Review.
Cited by
-
Pancreatic cancer incidence and mortality trends in urban Shanghai, China from 1973 to 2017: a joinpoint regression and age-period-cohort analysis.Front Oncol. 2023 Jul 27;13:1113301. doi: 10.3389/fonc.2023.1113301. eCollection 2023. Front Oncol. 2023. PMID: 37576894 Free PMC article.
-
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants.Fam Cancer. 2024 Aug;23(3):233-246. doi: 10.1007/s10689-024-00397-w. Epub 2024 May 23. Fam Cancer. 2024. PMID: 38780705 Free PMC article.
-
A Guide for Selection of Genetic Instruments in Mendelian Randomization Studies of Type 2 Diabetes and HbA1c: Toward an Integrated Approach.Diabetes. 2023 Feb 1;72(2):175-183. doi: 10.2337/db22-0110. Diabetes. 2023. PMID: 36669000 Free PMC article.
-
Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records.BMC Cancer. 2021 Nov 27;21(1):1279. doi: 10.1186/s12885-021-09014-w. BMC Cancer. 2021. PMID: 34837975 Free PMC article.
-
Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: Results from a longitudinal cohort and mendelian randomization study.Lancet Reg Health West Pac. 2022 Sep 17;30:100596. doi: 10.1016/j.lanwpc.2022.100596. eCollection 2023 Jan. Lancet Reg Health West Pac. 2022. PMID: 36419740 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical